nodes	percent_of_prediction	percent_of_DWPC	metapath
Iohexol—Convulsion—Mycophenolic acid—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Iohexol—Muscle spasms—Lisinopril—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Iohexol—Rash—Pentoxifylline—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Iohexol—Hypertension—Mycophenolic acid—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Iohexol—Dermatitis—Pentoxifylline—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Iohexol—Headache—Pentoxifylline—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Iohexol—Thrombophlebitis—Methotrexate—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Iohexol—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Iohexol—Feeling abnormal—Captopril—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Iohexol—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Iohexol—Gastrointestinal pain—Captopril—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Iohexol—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Iohexol—Hypotension—Azathioprine—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Iohexol—Cardiac arrest—Prednisone—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Iohexol—Tremor—Lisinopril—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Iohexol—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Iohexol—Discomfort—Mycophenolic acid—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Iohexol—Nervous system disorder—Leflunomide—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Iohexol—Pruritus—Mometasone—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Iohexol—Skin disorder—Leflunomide—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Iohexol—Angioedema—Lisinopril—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Iohexol—Confusional state—Mycophenolic acid—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Iohexol—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Iohexol—Abdominal pain—Captopril—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Iohexol—Body temperature increased—Captopril—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Iohexol—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Iohexol—Nausea—Pentoxifylline—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Iohexol—Malaise—Lisinopril—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Iohexol—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Iohexol—Diarrhoea—Mometasone—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Iohexol—Syncope—Lisinopril—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Iohexol—Shock—Mycophenolic acid—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Iohexol—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Iohexol—Hypotension—Leflunomide—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Iohexol—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Iohexol—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Iohexol—Loss of consciousness—Lisinopril—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Iohexol—Cough—Lisinopril—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Iohexol—Muscular weakness—Prednisone—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Iohexol—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Iohexol—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Iohexol—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Iohexol—Paraesthesia—Leflunomide—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Iohexol—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Iohexol—Arthralgia—Lisinopril—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Iohexol—Dyspnoea—Leflunomide—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Iohexol—Hypotension—Mycophenolic acid—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Iohexol—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Iohexol—Discomfort—Lisinopril—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Iohexol—Pancreatitis—Prednisone—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Iohexol—Vomiting—Mometasone—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Iohexol—Feeling abnormal—Azathioprine—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Iohexol—Rash—Mometasone—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Iohexol—Dermatitis—Mometasone—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Iohexol—Confusional state—Lisinopril—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Iohexol—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Iohexol—Headache—Mometasone—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Iohexol—Tremor—Mycophenolate mofetil—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Iohexol—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Iohexol—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Iohexol—Pruritus—Captopril—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Iohexol—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Iohexol—Pain—Leflunomide—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Iohexol—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Iohexol—Somnolence—Mycophenolic acid—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Iohexol—Shock—Lisinopril—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Iohexol—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Iohexol—Abdominal pain—Azathioprine—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Iohexol—Body temperature increased—Azathioprine—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Iohexol—Skin disorder—Lisinopril—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Iohexol—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Iohexol—Diarrhoea—Captopril—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Iohexol—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Iohexol—Feeling abnormal—Leflunomide—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Iohexol—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Iohexol—Nausea—Mometasone—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Iohexol—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Iohexol—Pain—Mycophenolic acid—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Iohexol—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Iohexol—Cough—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Iohexol—Hypotension—Lisinopril—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Iohexol—Dizziness—Captopril—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Iohexol—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Iohexol—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Iohexol—Urticaria—Leflunomide—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Iohexol—Body temperature increased—Leflunomide—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Iohexol—Abdominal pain—Leflunomide—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Iohexol—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Iohexol—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Iohexol—Hypersensitivity—Azathioprine—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Iohexol—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Iohexol—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Iohexol—Paraesthesia—Lisinopril—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Iohexol—Vomiting—Captopril—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Iohexol—Dyspnoea—Lisinopril—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Iohexol—Rash—Captopril—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Iohexol—Dermatitis—Captopril—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Iohexol—Somnolence—Lisinopril—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Iohexol—Headache—Captopril—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Iohexol—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Iohexol—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Iohexol—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Iohexol—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Iohexol—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Iohexol—Shock—Mycophenolate mofetil—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Iohexol—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Iohexol—Hypersensitivity—Leflunomide—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Iohexol—Pancreatitis—Methotrexate—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Iohexol—Pain—Lisinopril—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Iohexol—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Iohexol—Bradycardia—Prednisone—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Iohexol—Diarrhoea—Azathioprine—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Iohexol—Nausea—Captopril—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Iohexol—Feeling abnormal—Lisinopril—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Iohexol—Pruritus—Leflunomide—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Iohexol—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Iohexol—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Iohexol—Dizziness—Azathioprine—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Iohexol—Diarrhoea—Leflunomide—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Iohexol—Urticaria—Lisinopril—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Iohexol—Abdominal pain—Lisinopril—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Iohexol—Body temperature increased—Lisinopril—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Iohexol—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Iohexol—Pruritus—Mycophenolic acid—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Iohexol—Vomiting—Azathioprine—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Iohexol—Eye disorder—Prednisone—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Iohexol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Iohexol—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Iohexol—Rash—Azathioprine—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Iohexol—Dermatitis—Azathioprine—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Iohexol—Flushing—Prednisone—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Iohexol—Headache—Azathioprine—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Iohexol—Dizziness—Leflunomide—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Iohexol—Renal failure—Methotrexate—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Iohexol—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Iohexol—Angiopathy—Prednisone—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Iohexol—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Iohexol—Immune system disorder—Prednisone—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Iohexol—Pain—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Iohexol—Arrhythmia—Prednisone—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Iohexol—Vomiting—Leflunomide—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Iohexol—Hypersensitivity—Lisinopril—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Iohexol—Dizziness—Mycophenolic acid—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Iohexol—Rash—Leflunomide—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Iohexol—Dermatitis—Leflunomide—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Iohexol—Mental disorder—Prednisone—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Iohexol—Nausea—Azathioprine—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Iohexol—Headache—Leflunomide—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Iohexol—Erythema—Prednisone—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Iohexol—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Iohexol—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Iohexol—Pruritus—Lisinopril—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Iohexol—Vomiting—Mycophenolic acid—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Iohexol—Rash—Mycophenolic acid—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Iohexol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Iohexol—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Iohexol—Headache—Mycophenolic acid—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Iohexol—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Iohexol—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Iohexol—Nausea—Leflunomide—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Iohexol—Urinary tract disorder—Methotrexate—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Iohexol—Urethral disorder—Methotrexate—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Iohexol—Diarrhoea—Lisinopril—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Iohexol—Angioedema—Prednisone—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Iohexol—Dizziness—Lisinopril—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Iohexol—Nausea—Mycophenolic acid—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Iohexol—Malaise—Prednisone—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Iohexol—Eye disorder—Methotrexate—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Iohexol—Syncope—Prednisone—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Iohexol—Cardiac disorder—Methotrexate—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Iohexol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Iohexol—Loss of consciousness—Prednisone—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Iohexol—Vomiting—Lisinopril—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Iohexol—Angiopathy—Methotrexate—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Iohexol—Immune system disorder—Methotrexate—systemic scleroderma	0.001	0.001	CcSEcCtD
Iohexol—Rash—Lisinopril—systemic scleroderma	0.001	0.001	CcSEcCtD
Iohexol—Convulsion—Prednisone—systemic scleroderma	0.001	0.001	CcSEcCtD
Iohexol—Dermatitis—Lisinopril—systemic scleroderma	0.001	0.001	CcSEcCtD
Iohexol—Mediastinal disorder—Methotrexate—systemic scleroderma	0.001	0.001	CcSEcCtD
Iohexol—Hypertension—Prednisone—systemic scleroderma	0.001	0.001	CcSEcCtD
Iohexol—Headache—Lisinopril—systemic scleroderma	0.000998	0.000998	CcSEcCtD
Iohexol—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000987	0.000987	CcSEcCtD
Iohexol—Arthralgia—Prednisone—systemic scleroderma	0.000987	0.000987	CcSEcCtD
Iohexol—Discomfort—Prednisone—systemic scleroderma	0.000975	0.000975	CcSEcCtD
Iohexol—Mental disorder—Methotrexate—systemic scleroderma	0.000975	0.000975	CcSEcCtD
Iohexol—Erythema—Methotrexate—systemic scleroderma	0.000969	0.000969	CcSEcCtD
Iohexol—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000955	0.000955	CcSEcCtD
Iohexol—Dysgeusia—Methotrexate—systemic scleroderma	0.000948	0.000948	CcSEcCtD
Iohexol—Nausea—Lisinopril—systemic scleroderma	0.000946	0.000946	CcSEcCtD
Iohexol—Anaphylactic shock—Prednisone—systemic scleroderma	0.000946	0.000946	CcSEcCtD
Iohexol—Shock—Prednisone—systemic scleroderma	0.000931	0.000931	CcSEcCtD
Iohexol—Nervous system disorder—Prednisone—systemic scleroderma	0.000928	0.000928	CcSEcCtD
Iohexol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000923	0.000923	CcSEcCtD
Iohexol—Skin disorder—Prednisone—systemic scleroderma	0.000919	0.000919	CcSEcCtD
Iohexol—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000887	0.000887	CcSEcCtD
Iohexol—Rash—Mycophenolate mofetil—systemic scleroderma	0.00088	0.00088	CcSEcCtD
Iohexol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000879	0.000879	CcSEcCtD
Iohexol—Headache—Mycophenolate mofetil—systemic scleroderma	0.000874	0.000874	CcSEcCtD
Iohexol—Malaise—Methotrexate—systemic scleroderma	0.000873	0.000873	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000862	0.000862	CcSEcCtD
Iohexol—Paraesthesia—Prednisone—systemic scleroderma	0.000849	0.000849	CcSEcCtD
Iohexol—Cough—Methotrexate—systemic scleroderma	0.000845	0.000845	CcSEcCtD
Iohexol—Convulsion—Methotrexate—systemic scleroderma	0.000839	0.000839	CcSEcCtD
Iohexol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000829	0.000829	CcSEcCtD
Iohexol—Arthralgia—Methotrexate—systemic scleroderma	0.000825	0.000825	CcSEcCtD
Iohexol—Discomfort—Methotrexate—systemic scleroderma	0.000815	0.000815	CcSEcCtD
Iohexol—Confusional state—Methotrexate—systemic scleroderma	0.000797	0.000797	CcSEcCtD
Iohexol—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00079	0.00079	CcSEcCtD
Iohexol—Feeling abnormal—Prednisone—systemic scleroderma	0.000779	0.000779	CcSEcCtD
Iohexol—Nervous system disorder—Methotrexate—systemic scleroderma	0.000775	0.000775	CcSEcCtD
Iohexol—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000773	0.000773	CcSEcCtD
Iohexol—Skin disorder—Methotrexate—systemic scleroderma	0.000768	0.000768	CcSEcCtD
Iohexol—Urticaria—Prednisone—systemic scleroderma	0.000751	0.000751	CcSEcCtD
Iohexol—Abdominal pain—Prednisone—systemic scleroderma	0.000748	0.000748	CcSEcCtD
Iohexol—Body temperature increased—Prednisone—systemic scleroderma	0.000748	0.000748	CcSEcCtD
Iohexol—Hypotension—Methotrexate—systemic scleroderma	0.000739	0.000739	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00072	0.00072	CcSEcCtD
Iohexol—Paraesthesia—Methotrexate—systemic scleroderma	0.00071	0.00071	CcSEcCtD
Iohexol—Dyspnoea—Methotrexate—systemic scleroderma	0.000705	0.000705	CcSEcCtD
Iohexol—Somnolence—Methotrexate—systemic scleroderma	0.000703	0.000703	CcSEcCtD
Iohexol—Hypersensitivity—Prednisone—systemic scleroderma	0.000697	0.000697	CcSEcCtD
Iohexol—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000682	0.000682	CcSEcCtD
Iohexol—Pain—Methotrexate—systemic scleroderma	0.000676	0.000676	CcSEcCtD
Iohexol—Pruritus—Prednisone—systemic scleroderma	0.000669	0.000669	CcSEcCtD
Iohexol—Feeling abnormal—Methotrexate—systemic scleroderma	0.000651	0.000651	CcSEcCtD
Iohexol—Diarrhoea—Prednisone—systemic scleroderma	0.000647	0.000647	CcSEcCtD
Iohexol—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000646	0.000646	CcSEcCtD
Iohexol—Urticaria—Methotrexate—systemic scleroderma	0.000628	0.000628	CcSEcCtD
Iohexol—Dizziness—Prednisone—systemic scleroderma	0.000625	0.000625	CcSEcCtD
Iohexol—Abdominal pain—Methotrexate—systemic scleroderma	0.000625	0.000625	CcSEcCtD
Iohexol—Body temperature increased—Methotrexate—systemic scleroderma	0.000625	0.000625	CcSEcCtD
Iohexol—Vomiting—Prednisone—systemic scleroderma	0.000601	0.000601	CcSEcCtD
Iohexol—Rash—Prednisone—systemic scleroderma	0.000596	0.000596	CcSEcCtD
Iohexol—Dermatitis—Prednisone—systemic scleroderma	0.000596	0.000596	CcSEcCtD
Iohexol—Headache—Prednisone—systemic scleroderma	0.000593	0.000593	CcSEcCtD
Iohexol—Hypersensitivity—Methotrexate—systemic scleroderma	0.000582	0.000582	CcSEcCtD
Iohexol—Nausea—Prednisone—systemic scleroderma	0.000562	0.000562	CcSEcCtD
Iohexol—Pruritus—Methotrexate—systemic scleroderma	0.000559	0.000559	CcSEcCtD
Iohexol—Diarrhoea—Methotrexate—systemic scleroderma	0.000541	0.000541	CcSEcCtD
Iohexol—Dizziness—Methotrexate—systemic scleroderma	0.000523	0.000523	CcSEcCtD
Iohexol—Vomiting—Methotrexate—systemic scleroderma	0.000503	0.000503	CcSEcCtD
Iohexol—Rash—Methotrexate—systemic scleroderma	0.000498	0.000498	CcSEcCtD
Iohexol—Dermatitis—Methotrexate—systemic scleroderma	0.000498	0.000498	CcSEcCtD
Iohexol—Headache—Methotrexate—systemic scleroderma	0.000495	0.000495	CcSEcCtD
Iohexol—Nausea—Methotrexate—systemic scleroderma	0.00047	0.00047	CcSEcCtD
